Treatment Selection and Survival Outcomes in Early-Stage Peripheral T-Cell Lymphomas: Does Anaplastic Lymphoma Kinase Mutation Impact the Benefit of Consolidative Radiation Therapy?

Abstract

Peer reviewed

J.A. Vargo, G. Balasubramani and S. Beriwal

International journal of radiation oncology, biology, physics, v 99(2), pp S141-S141

01 Oct 2017

Additional Links

5 Record Views

Title: Treatment Selection and Survival Outcomes in Early-Stage Peripheral T-Cell Lymphomas: Does Anaplastic Lymphoma Kinase Mutation Impact the Benefit of Consolidative Radiation Therapy?
Creators: J.A. Vargo - UPMC Hillman Cancer Center
G. Balasubramani - University of Pittsburgh
S. Beriwal - UPMC Hillman Cancer Center
Publication Details: International journal of radiation oncology, biology, physics, v 99(2), pp S141-S141
Publisher: Elsevier; NEW YORK
Number of pages: 1
Resource Type: Abstract
Language: English
Academic Unit: Radiation Oncology (and Nuclear Medicine)
Web of Science ID: WOS:000411559107115
Other Identifier: 991021897363604721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging